Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,843 | Dovepress* | 4,358+ | 344 | 4,702 | |
| PubMed Central* | 485 | 242 | 727 | ||
| Totals | 4,843 | 586 | 5,429 | ||
| *Since 15 September 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar